TIRZ

TIRZ is a synthetic 39-amino acid dual agonist peptide targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This research compound incorporates a C20 fatty diacid modification for enhanced stability and demonstrates dual incretin receptor activity. TIRZ is classified as a dual incretin receptor agonist for research applications investigating glucose homeostasis and metabolic regulation.